NCT05944523

Brief Summary

The patients who will participate in the study will be determined and informed according to the inclusion and exclusion criteria, and the patients who signed the informed consent form will be included in the study.52 patients who will undergo elective thoracotomy surgery will be divided into double-blinded 2 sided as preemptive and postoperative erector spina plane block. Intraoperative pain status of the patients will be determined by the "Nociception Level Index" device and analgesia will be provided with fentanyl. The primary aim of the study is to compare the intraoperative opioid consumption of two groups with plan block at different times. In the postoperative period, patient-controlled analgesia device will be given to both groups for rescue analgesia. The opioid consumption of the patients will be controlled in this way in the postoperative period and their pain status will be determined. The secondary aim of the study is to examine the effect of plan block application time on the postoperative period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 6, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 13, 2023

Completed
Last Updated

July 13, 2023

Status Verified

July 1, 2023

Enrollment Period

1 year

First QC Date

July 6, 2023

Last Update Submit

July 12, 2023

Conditions

Keywords

preemptive analgesiaerector spina plan blocknociception level (NoL) indexthoracotomyopioid consumption

Outcome Measures

Primary Outcomes (1)

  • The value of Nociception Level Index (NoL) in both preemptive and postoperative groups

    We aim to determine the effect of preemptive or postoperative application of ESPB ın the amount of intraopioid consumption by Nociception Level Index

    Up to 24 hours

Study Arms (2)

Group 1

ACTIVE COMPARATOR

The group in which preemptive erector spina plane block was applied

Procedure: Erector Spina Plan Block

Group 2

ACTIVE COMPARATOR

The group in which the end of the surgery was applied to the erector spina plane block

Procedure: Erector Spina Plan Block

Interventions

Preemptive erector spina plan block and postoperative erector spina plan block were applied to patients undergoing thoracotomy. The effect of the time of application on intraoperative opioid consumption was compared with the Nociception Level Index pain monitor.

Group 1Group 2

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18-65 years
  • ASA classification \<4
  • No history of allergy or hypersensitivity to the drugs we use throughout the procedure
  • BMI ≤ 35
  • No history of neuropathy
  • Surgeries other than emergency surgery
  • Volunteer for the study
  • No presence of infection at the injection site
  • No any pyschiatric disease that would prevent the evaluation of the pain score

You may not qualify if:

  • Under the age of 18 or over the age of 65
  • ASA classification ≥ 4
  • History of allergy or hypersensitivity to the drugs we use throughout the procedure
  • BMI \> 35
  • History of neuropathy
  • Undergoing emergency surgery
  • Not be a volunteer for the study
  • Presence of infection at the injection site
  • Having a pyschiatric disease that would prevent the evaluation of the pain score
  • Pregnancy
  • Undergo surgery again during the postoperative follow-up period for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Ankara University

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Erythema Multiforme

Condition Hierarchy (Ancestors)

ErythemaSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, Vesiculobullous

Study Officials

  • Neslihan Alkış, Prof. Dr.

    Faculty of Medicine, Ankara University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

July 6, 2023

First Posted

July 13, 2023

Study Start

January 1, 2022

Primary Completion

January 1, 2023

Study Completion

May 1, 2023

Last Updated

July 13, 2023

Record last verified: 2023-07

Locations